Lexpos News

The UK Covid-19 Inquiry is seeking input from pharmacists nationwide, to share your pandemic experiences through the Every Story Matters initiative. Recognising the crucial role played by community pharmacy during the pandemic, the Inquiry is keen to gather the unique experiences and stories from pharmacists and their teams. This campaign provides people with a chance [...]

The post UK Covid-19 Inquiry: Every Story Matters appeared first on Community Pharmacy England.

Drug alert number: EL (23)A/25 Date issued: 10 July 2023 The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 2 medicines recall for: Sabril 500 mg film-coated tablets & Sabril 500 mg granules for oral solution (Aventis Pharma Limited (t/a Sanofi)) Product name Sabril 500 mg film-coated tablets, PL 04425/0171 Batch number [...]

The post MHRA Class 2 Medicines Recall: Sabril 500 mg film-coated tablets & 500 mg granules for oral solution (Aventis Pharma Limited (t/a Sanofi)) appeared first on Community Pharmacy England.

Date issued: 13 July 2023 The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 2 medicines recall for: Sabril 500 mg film-coated tablets & Sabril 500 mg granules for oral solution. Sabril 500 mg film-coated tablets Pl 04425/0171 Batch number Expiry date Pack size First distributed 2989A April 2025 100 02/08/22 2988D [...]

The post MHRA Class 2 Medicines Recall: Sabril 500mg film-coated tablets and 500mg granules for oral solution (Aventis Pharma Limited (t/a Sanofi) appeared first on Community Pharmacy England.

Following discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners (our members), the Department has today (13/07/2023) announced the following initial list of price concessions for July 2023: Drug Pack size Price concession Amisulpride 100mg tablets 60 £18.15 Atorvastatin 10mg tablets 28 [...]

The post July 2023 Price Concessions 1st Update appeared first on Community Pharmacy England.

Class 4 Medicines Defect Information: Cipla (UK) Limited and Pharmathen S.A – Various Products Drug alert number:EL (23)A/24 Date issued: 13 July 2023 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Cipla (UK) Limited and Pharmathen S.A – Various Products Company name: Cipla (EU) Limited, [...]

The post Class 4 Medicines Defect Information: Cipla (UK) Limited and Pharmathen S.A – Various Products appeared first on Community Pharmacy England.